Shenzhen Reborngene Therapeutics Co., Ltd.
Shenzhen Reborngene Therapeutics Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RB001 Gene Therapy Study in Children With SHANK3-related Phelan-McDermid Syndrome (PMS) | Phelan-McDermid syndrome | Active, not recruiting | Phase 1 | 2026-07-28 | NCT07014020 | |
| Long-Term Follow-Up Study for RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS) | Phelan-McDermid syndrome | Enrolling by invitation | Phase 1 | 2026-07-13 | NCT07690527 |